GNI Group (2160) · FactRestated
Potential CTD-ILD patient population exceeds that of IPF
First written in FY2016-Q3. 1 of 2 entries say "Restated". Latest entry: FY2017-Q3.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Potential Patient Market Size for CTD-ILDA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2017-Q3RestatedAnnual report
「CTD-ILD又は未分化組織結合病間質性肺疾患（UCTD-ILD）の患者数はIPF患者数の２倍近くとの報告があります。」
CTD-ILD又はUCTD-ILDの患者数がIPF患者数の約2倍との報告を再掲している。 - FY2016-Q3First statedAnnual report
「Although the number of CTD-ILD patients in China is unclear, reports indicate that within certain populations of patients with interstitial lung disease (ILD), the number of patients with CTD-ILD or undifferentiated connective tissue disease-associated interstitial lung disease (UCTD-ILD) is nearly twice the number of patients with idiopathic pulmonary fibrosis (IPF). This suggests that CTD-ILD and UCTD-ILD have a higher prevalence than IPF.」
The company cites reports that the number of CTD-ILD and UCTD-ILD patients is approximately twice the number of IPF patients, suggesting a potentially higher prevalence of CTD-ILD than IPF.